Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
232
天
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands – A nationwide study of drug usage and treatment outcomes
作者
Benno Diekmann; Carolien M. Woolthuis; Maarten F. Corsten; David de Leeuw; Roel B. Fiets; Elena Segarceanu; Fleur M. van der Valk; Tim T. de Waal; Marjan Cruijsen; Eva de Jongh; Tjeerd Snijders; Danielle van Lammeren; Aart Beeker; Alexandra H.E. Herbers; Lidwine Tick; Bas Franken; Nic J.G.M. Veeger; Eric N. van Roon; Mels Hoogendoorn展开收起
作者单位
Department of Pharmacotherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, University Medical Center Groningen, The Netherlands; Department of Oncology, Meander Medical Centre, The Netherlands; Department of Internal Medicine, Vrije Universiteit Medical Center, The Netherlands; Department of Oncology, Amphia Hospital Breda, The Netherlands; Department of Oncology, Saint Antonius Hospital Nieuwegein, The Netherlands; Department of Oncology, Onze Lieve Vrouw Gasthuis, Amsterdam, The Netherlands; Department of Oncology, Isala Hospital Zwolle, The Netherlands; Department of Oncology, Catharina Hospital Eindhoven, The Netherlands; Department of Oncology, Albert Schweitzer Hospital Dordrecht, The Netherlands; Department of Oncology, Medisch Spectrum Twente, The Netherlands; Department of Oncology, HAGA Hospital The Hague, The Netherlands; Department of Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands; Department of Oncology, Jeroen Bosch Hospital, The Netherlands; Department of Oncology, Maxima Medical Centre, Eindhoven, The Netherlands; Department of Internal Medicine, Frisius Medical Centre, Leeuwarden, The Netherlands; Frisius Medical Centre Academy, Frisius Medical Centre, Leeuwarden, The Netherlands; Department of Clinical Pharmacy & Pharmacology, Frisius Medical Centre, Leeuwarden, The Netherlands展开收起
107
天
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients
作者
Tanja C. van Dijk; Marcel Smid; Debbie G.J. Robbrecht; Khrystany T. Isebia; John W.M. Martens; Nick Beije展开收起
作者单位
Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, Rotterdam 3015 GD, the Netherlands展开收起
84
天
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy
作者
Ariane Steindl; Angelika M. Starzer; Erwin Tomasich; Markus Kleinberger; Luzia Berchtold; Franziska Eckert; Georg Widhalm; Brigitte Gatterbauer; Johannes A. Hainfellner; Lisa Wozelka-Oltjan; Bekir Erguener; Michael Schuster; Christoph Bock; Gerwin Heller; Matthias Preusser; Anna.S. Berghoff展开收起
作者单位
Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria; Department of Radiation Oncology, Medical University of Vienna, Austria; Department of Neurosurgery, Medical University of Vienna, Austria; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria; Department of Pathology, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天